Gleason Score News and Research

RSS
Surgery may not prolong life in men with early-stage prostate cancer

Surgery may not prolong life in men with early-stage prostate cancer

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Protein testing may become potential tool to detect prostate cancer

Protein testing may become potential tool to detect prostate cancer

New genetic test may give men better view on how to deal with prostate cancer risk

New genetic test may give men better view on how to deal with prostate cancer risk

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Management of prostate cancer varies by race

Management of prostate cancer varies by race

Active surveillance improves health related quality of life in low risk prostate cancer patients

Active surveillance improves health related quality of life in low risk prostate cancer patients

Changes in benign tissue adjacent to prostate tumors could better predict recurrence

Changes in benign tissue adjacent to prostate tumors could better predict recurrence

Study assesses risk factors for metastases in prostate cancer patients on active surveillance

Study assesses risk factors for metastases in prostate cancer patients on active surveillance

Experimental urine test identifies 92% of men with elevated PSA levels

Experimental urine test identifies 92% of men with elevated PSA levels

ANGLE’s Parsortix system may be used for detection of prostate cancer, Barts patient data suggests

ANGLE’s Parsortix system may be used for detection of prostate cancer, Barts patient data suggests

ZYTIGA plus prednisone provides overall survival benefit in men with early and less aggressive mCRPC

ZYTIGA plus prednisone provides overall survival benefit in men with early and less aggressive mCRPC

New study finds link between vitamin D deficiency and aggressive prostate cancer

New study finds link between vitamin D deficiency and aggressive prostate cancer

African American men with prostate cancer have significantly lower PSA density than Caucasian men

African American men with prostate cancer have significantly lower PSA density than Caucasian men

New research finds five different types of prostate cancer

New research finds five different types of prostate cancer

PSMA PET imaging more precise than MR imaging for detection of high-grade prostate cancer lesions

PSMA PET imaging more precise than MR imaging for detection of high-grade prostate cancer lesions

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

Prostate cancer discovery may improve treatment strategies

Prostate cancer discovery may improve treatment strategies

Cancer Research UK scientists identify five distinct types of prostate cancer

Cancer Research UK scientists identify five distinct types of prostate cancer